Table 3 Univariable analyses of interactions between continuous TROP-2 expression and continuous clinical–pathological variables.

From: Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer

Association of TROP-2 score with

Correlation statistics

Spearman correlation (ρ

95% confidence interval

p-value

sTILs

Spearman

0.018

(− 0.063; 0.098)

0.6713

AR expression

Spearman

0.130

(0.050; 0.209)

0.0016

Standardized mitotic index

Spearman

0.013

(− 0.080; 0.105)

0.7861

Age

Spearman

 − 0.025

(− 0.106; 0.056)

0.5450

BMI

Spearman

 − 0.090

(− 0.169; − 0.009)

0.0299

  1. AR androgen receptor, sTILs stromal tumor-infiltrating lymphocytes.
Back to article page